Credence ID mobile biometrics selected for better patient management in Senegal
Credence ID has announced it has been chosen to deploy its mobile biometrics and credential reading technology for patient identity confirmation in Senegal with the goal of reducing fraud and improving record-keeping in the country’s healthcare delivery system.
The U.S. company said in a statement that it was chosen following a competitive contest for a bid that also had the support of the World Bank. The project is expected to improve access to prenatal, neonatal, and COVID-19 related services across the West African nation’s clinics and health centers.
According to Credence ID, the new system will see its mobile biometric tablets (CredenceTAB) and fixed workstations used for the confirmation of patients’ identity. These will be fully integrated into the country’s national health database in a way as to allow for smooth work progress between staff in the service provision chain.
The firm said it will also be using its enrollment, identification and verification software, VIBE, which is further enhance by native integration with CredenceCONNECT, on both mobile devices and desktops, enabling the Senegalese health ministry to track, analyze and map its ID equipment, check each device’s activity, wirelessly update their applications, SDKs, and algorithms, and lock devices to specific applications, with what Credence describes as an intuitive and secure interface.
Bruce Hanson, president and CEO of Credence ID expressed gratitude over the selection of his company, which he said went through “a rigorous selection process.”
“Getting patient identity right, especially now, is where the power of mobile biometrics can make a huge difference in healthcare outcomes. The combination of our certified ID hardware and software solutions, superior customer support and affordability for emerging markets are what set Credence ID apart,” Hanson said.